Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

USP37 activates APC. 3 / 3

| 3

➶

reach

"Other APC CDH1 substrates, including CDC20, CDC6, PLK1, Aurora kinase A, and SKP2, were not decreased by USP37 knockdown, indicating a specific effect of USP37 on cyclin A abundance.Coimmunoprecipitat[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

21596315

➶

reach

"Deubiquitinase USP37 is activated by CDK2 to antagonize APC (CDH1) and promote S phase entry [XREF_BIBR]."

25972356

➶

reach

"Deubiquitinase USP37 is activated by CDK2 to antagonize APC (CDH1) and promote S phase entry."

21596315

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...

Other Services

This Service

This Project

IndraLab

Statements

USP37 activates APC. 3 / 3

Our Sources:

Databases

Reading